Cyclic Functional Electrical Stimulation Does Not Enhance Gains in Hand Grasp Function When Used as an Adjunct to OnabotulinumtoxinA and Task Practice Therapy: A Single-Blind, Randomized Controlled Pilot Study Douglas J. Weber, PhD, Elizabeth R. Skidmore, PhD, OTR/L, Christian Niyonkuru, MS, Chia-Lin Chang, PhD, PT, Lynne M. Huber, BS, OTR/L, Michael C. Munin, MD Archives of Physical Medicine and Rehabilitation Volume 91, Issue 5, Pages 679-686 (May 2010) DOI: 10.1016/j.apmr.2010.01.010 Copyright © 2010 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 1 Consolidated Standards of Reporting Trials (CONSORT) diagram. Archives of Physical Medicine and Rehabilitation 2010 91, 679-686DOI: (10.1016/j.apmr.2010.01.010) Copyright © 2010 American Congress of Rehabilitation Medicine Terms and Conditions
Fig 2 Outcomes for motor function change over time. (A) Motor Activity Log–Observation, (B) Motor Activity Log–Self-Report, (C) the ARAT. Plots show the group averages at BL, week 6, and week 12 time points. MALO and MALSR scores represent mean item score (range, 0–5). ARAT scores represent total scale score (range, 0–57). No-FES: subjects who received onabotulinumtoxinA injections and task practice therapy. FES: subjects who received cyclic FES in addition to onabotulinumtoxinA injections and task practice therapy. Abbreviations: BL, baseline; MALO, Motor Activity Log–Observation; MALSR, Motor Activity Log–Self-Report. Archives of Physical Medicine and Rehabilitation 2010 91, 679-686DOI: (10.1016/j.apmr.2010.01.010) Copyright © 2010 American Congress of Rehabilitation Medicine Terms and Conditions